Manufacture of pharmaceutical preparations
NORSK MEDISINSK SYKLOTRONSENTER AS
Revenue 2024
NOK 108.3m
Operating profit
NOK −3.1m
Equity
NOK 13.7m
Incorporated
2003
Employees
54
Share capital
NOK 500,000
Key figures · 2024
Current ratio
0.69
Equity ratio
20.2%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -2.9% | |
| Net margin (%%) | -3.9% | |
| Return on assets (%%) | -4.6% | |
| Likviditet | ||
| Current ratio | 0.69 | |
| Working capital | −8.9m | |
| Soliditet | ||
| Equity ratio (%%) | 20.2% | |
| Debt-to-equity ratio | 3.96 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.